Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity

Cancer Letters

Volumn 128, Issue 1, 1998, Pages 41-46

  Bae, Myung Ho ^a   Lee, Myoung Jin ^b   Bae, Soo Kyung ^a   Lee, Ok Hee ^a   Lee, You Mie ^a   Park, Byung Chae ^c   Kim, Kyu Won ^a  

^a Pusan National University   (South Korea)

^b Yeungnam University   (South Korea)

^c Kosin University   (South Korea)

Author keywords

Angiogenesis; HepG2 cells; Insulin like growth factor II

Indexed keywords

ANGIOGENIC FACTOR; SOMATOMEDIN B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ALLANTOIS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CHICK EMBRYO; CHORION; CULTURE MEDIA, CONDITIONED; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032486339     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00044-5     Document Type: Article

References (25)

1. Gimbrone M.A., Leapman S.B., Cotran R.S., Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136:1992;261-276.
2. Blood C.H., Zetter B.R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochem. Biophys. Acta. 1032:1990;89-118.
3. World Health Organization Reports of the WHO Expert Committee on Viral Hepatitis. WHO Tech. Rep. Ser. Adv. Viral Hepatitis. 602:1977;7-47.
4. Mise M., Arii S., Higashituji H., Furutani M., Niwano M., Harada T., Ishigami S., Toda Y., Nakayama H., Fukmoto M., Fujita J., Imamura M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology. 23:1996;455-464.
5. Yang D.Y., Rogler C.E. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of the woodchuck utilizing in situ hybridization and immunohistochemistry. Carcinogenesis. 12:1991;1893-1901.
6. Cariani E., Lasserre C., Seurin D., Hamelin B., Kemeny F., Franco D., Czech M.P., Ullrich A., Brechot C. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res. 48:1988;6844-6849.
7. Park B.C., Huh M.H., Seo J.H. Differential expression of transforming growth factor α and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. J. Hepatol. 22:1995;286-294.
8. Grant M.B., Mames R.N., Fitzgerald C., Ellis E.A., Aboufriekha M., Guy J. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia. 36:1993;282-291.
9. Hylka V.W., Kent S.B., Straus D.S. E-Domain peptide of rat proinsulin-like growth factor-II: validation of a radioimmunoassay and measurement in culture medium and rat serum. Endocrinology. 120:1987;2050-2058.
10. Yang E.Y., Moses H.L. Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111:1990;731-741.
11. Nguyen M., Shing Y., Folkman J. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47:1994;31-40.
12. Crum R., Szabo S., Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 230:1985;1375-1378.
13. Towin H.T., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
14. Jürgen Z., Eva F., Martina P., Froesch R. Can 'big' insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J. Clin. Invest. 90:1992;2574-2584.
15. Irminger J.C., Rosen K.M., Humbel R.E., Villa-Komaroff L. Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5′ untranslated regions. Proc. Natl. Acad. Sci. USA. 84:1987;6330-6334.
16. Lee W.H., Bowsher R.R., Apathy J.M., Smith M.C., Henry D.P. Measurement of insulin-like growth factor II in physiological fluids and tissues. II. Extraction and quantification in rat tissues. Endocrinology. 128:1991;815-822.
17. Stempien M.M., Fong N.M., Rall L.B., Bell G.I. Sequence of a placental cDNA encoding the mouse insulin-like growth factor II precursor. DNA. 5(5):1986;357-361.
18. Lamas E., Le Bail B., Housset C., Boucher O., Brechot C. Localization of insulin-like growth factor II and hepatitis B virus mRNA and proteins in human hepatocellular carcinomas. Lab. Invest. 64:1991;98-104.
19. Tanaka S., Takenaka K., Matsumata T., Mori R., Sugimachi K. Hepatitis C virus replication is associated with expression of transforming growth-factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig. Dis. Sci. 41:1996;208-215.
20. W.L. Lowe, Jr., Biological actions of the insulin-like growth factors, in: D. LeRoith (Ed.), Insulin-Like Growth Factors: Molecular and Cellular Aspects, CRC Press, Boca Raton, FL, 1991, pp. 49-85.
21. Valentinis B., Bhala A., DeAngelis T., Baserga R., Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9:1995;361-367.
22. Menuelle P., Binoux M., Plas C. Regulation by insulin-like growth factor (IGF) binding proteins of IGF-II-stimulated glycogenesis in cultured fetal rat hepatocytes. Endocrinology. 136:1995;5305-5310.
23. Mohan S., Bautista C.M., Wergedal J., Baylink D.J. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc. Natl. Acad. Sci. USA. 86:1989;8338-8342.
24. Ross M., Francis G.L., Szabo L., Wallace J.C., Ballard F.J. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3)-IGF-I. Biochem. J. 258:1989;267-272.
25. Wraight C.J., Werther G.A. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 105:1995;602-607.